Amyloidosis, Hereditary Clinical Trials

11 clinical trials for Amyloidosis, Hereditary across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers — RECRUITING
• A Phase 3 Study of NTLA-2001 in ATTRv-PN — RECRUITING · PHASE3
• ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers — RECRUITING
• Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry — NOT_YET_RECRUITING
• HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis) — COMPLETED · PHASE3
• Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran — ACTIVE_NOT_RECRUITING
• Prospective Evaluation of NfL as a Biomarker in ATTRv — ACTIVE_NOT_RECRUITING
• Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) — OTHER
• APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis — COMPLETED · PHASE3
• ATTR Expanded Access Program (EAP) by Ionis — OTHER
• ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) — COMPLETED · PHASE3

Refine this search